PharmaMar
Launch date
Employees
Market cap
$813m
Enterprise valuation
$707m (Public information from Sep 2024)
Share price
€47.52 PHM.MC
Colmenar Viejo Community of Madrid (HQ)
Financials
Estimates*
| EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 85.8m | 270m | 230m | 196m | 158m |
| % growth | - | 215 % | (15 %) | (15 %) | (19 %) |
| EBITDA | (11.4m) | 156m | 104m | 54.3m | 4.1m |
| % EBITDA margin | (13 %) | 58 % | 45 % | 28 % | 3 % |
| Profit | (11.4m) | 137m | 92.9m | 49.4m | 1.1m |
| % profit margin | (13 %) | 51 % | 40 % | 25 % | 1 % |
| R&D budget | 50.6m | 53.8m | 72.2m | 83.4m | 99.3m |
| R&D % of revenue | 59 % | 20 % | 31 % | 43 % | 63 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
* | $10.0m | Post IPO Equity | |
| Total Funding | - | ||